[O3] Oral Presentations 3

3:59 PM - 4:06 PM JST(6:59 AM - 7:06 AM UTC)

[O3-08] Development and Evaluation of a Next-Generation AAV Vector-Based Nucleic Acid Vaccine Platform

*Takashi OKADA¹ (1. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo (Japan))

Keywords:

AAV vector,Nucleic acid vaccine,Vexosome,Long-term immunity

Password required to view

Log in

or